A novel combination of tissue-informed, comprehensive genomic profiling (CGP) and non-bespoke blood-based profiling for quantifying circulating tumor DNA (ctDNA)

被引：1

|

作者：

Driessen, Terri

Lo, Christine

Zhu, Wei

Tell, Robert

Freaney, Jonathan

Nimeiri, Halla

Sasser, Kate

机构：

来源：

CANCER RESEARCH | 2024年 / 84卷 / 06期

关键词：

D O I：

10.1158/1538-7445.AM2024-3498

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3498

引用

收藏

页数：2

相关论文

共 43 条

[41] Retrospective clinical analysis of circulating tumor DNA (ctDNA)-based molecular response (MR) and baseline blood-based tumor mutational burden (bTMB) for monitoring response in phase 3 trial of bintrafusp alfa vs. pembrolizumab treatment of non-small cell lung cancer (NSCLC)
Feng, Zheng
Machl, Andreas
Wang, Danyi
Overstreet, Brooke
Yablonovitch, Arielle
Scheuenpflug, Juergen
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[42] Blood-based genomic profiling of cell-free DNA (cfDNA) to identify microsatellite instability (MSI-H), tumor mutational burden (TMB) and Wnt/B-Catenin pathway alterations in patients with gastrointestinal (GI) tract cancers.
Isaacs, James
Nixon, Andrew B.
Bolch, Emily
Quinn, Katie
Banks, Kimberly
Hanks, Brent Allen
Strickler, John H.
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[43] COMPREHENSIVE GENOMIC TESTING IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): A COST-EFFECTIVENESS ANALYSIS OF PLASMA-BASED CIRCULATING TUMOR DNA (CTDNA) NEXT-GENERATION SEQUENCING (NGS) TO INFORM FIRST-LINE TREATMENT DECISIONS
Lopes, G.
Liu, E.
Raymond, V
Scott, J.
Ho, V
Gandara, D.
VALUE IN HEALTH, 2020, 23 : S326 - S326

← 1 2 3 4 5 →